合并亚临床甲减的2型糖尿病患者临床及生化特征分析被引量：2

The Clinical and Biochemical Features of Patients with Type 2 Diabetes Complicated by Subclinical Hypothyroidism

下载PDF

导出

摘要目的探讨亚临床甲状腺功能减退症(SCH)对2型糖尿病(T2DM)患者血糖控制及代谢指标的影响.方法纳入住院的T2DM患者973例,测量身高、体重、血压,计算BMI;完善HbA1c、TC、TG、HDL-C、LDL-C、尿酸及甲状腺功能(TSH、TT4、TT3、FT4、FT3)检查.纳入的T2DM患者中筛查出合并SCH者148例(SCH组),在甲状腺功能正常的T2DM患者中选取性别、年龄及糖尿病病程相匹配的152例作为对照组(NSCH组).结果 (1)T2DM合并SCH的患病率为15.3%;(2)与NSCH组相比,SCH组超重/肥胖者比例(54.1%vs 35.5%,P<0.01)及高血压者比例(64.9%vs 52%,P<0.05)显著增高.两组间在HbA1c达标、高TC血症、高TG血症、低HDL血症、高LDL血症及高尿酸血症者比例无显著差异.结论 SCH对T2DM患者的血压、体重指数等代谢指标可能存在不良影响. Objective To investigate the effects of subclinical hypothyroidism （SCH） on blood glucose and metabolic parameters in type 2 diabetes （T2DM） . Methods A total of 973 T2DM patients were recruited, and the clinical data, biochemical and thyroid function parameters were measured. One hundred and forty eight T2DM patients were diagnosed as SCH （SCH group） and 152 euthyroid patients were selected as control group （NSCH group） . Results （1） The prevalence of SCH in type 2 diabetes was 15.3% （148/973）（2） Compared with the NSCH group, the prevalence of overweight/obesity was significantly higher in SCH group （54.1% vs 35.5%, P 〈 0.01） as well as hypertension （64.9% vs 52%, P 〈 0.05） . There was no significant difference in HbAlc control and prevalence of dyslipidemia and hyperuricemia between two groups. Conclusion SCH may have some

作者李全玉任秀莲苏恒牛奔张云薛元明

机构地区云南省第一人民医院内分泌科文山市人民医院包头市中心医院血液科

出处《昆明医科大学学报》 CAS 2013年第9期66-68,共3页 Journal of Kunming Medical University

基金云南省卫生科技内设研究机构资助项目(2011WS0006)

关键词临床甲状腺功能减退症糖尿病代谢指标 Subclinical hypothyroidism Diabetes mellitus Metabolic parameters

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献8

1KADIYALA R,PETER R,OKOSIEME O E. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies [ J ]. Int J Clin Pract, 2010,64 ( 8 ): 1 130-1 139.
2吴景程,李晓华,彭永德,程群.2型糖尿病患者中亚临床甲状腺功能减退症与糖尿病血管并发症关系的研究[J].中华内分泌代谢杂志,2010,26(4):304-306. 被引量：79
3刘薇,华琳,于湄,潘素芳,谢荣荣,杨金奎.亚临床甲状腺功能减退症对糖代谢的影响[J].首都医科大学学报,2008,29(6):773-777. 被引量：42
4MILIONIS H J,TAMBAKI A P,KANIOGLOI5 C N, et al. Thyroid substitution therapy induces high density lipoprotein associated platelet activating factor acetylhydrolase in patients with subclinical hypothyroidism:a potential antiatherogenic effect[ J ].Thyroid, 2005,15 ( 5 ) : 455 -460.
5TAKASHIMA N,NIWA Y,MANNAMI T,et al. Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints [J]. Circ J, 2007,71 (2) : 191-195.
6NAGASAKI T,INABA M,KUMEDA Y,et al. Increased pulse wave velocity in subclinical hypothyroidism [J]. J Clin Endocrinol Metab, 2006,91 (3) : 154- 158.
7WATERHOUSE D F,MCLAUGHLIN A M,WALSH C D, et al. An examination of the relationship between normal range thyrotropin and cardiovascular risk parameters: a study in healthy women [ J ]. Thyroid, 2007,17 (3) : 243 - 248.
8BASTEMIR M,AKIN F,ALKIS E,et al. Obesity is assoc- iated with inereased serum TSH level,independent of thyroid function [J]. Swiss Med Wkly,2007,137 (7) : 431 -434.

二级参考文献23

1刘薇,杨金奎.亚临床甲状腺机能减退研究进展[J].临床荟萃,2007,22(4):293-296. 被引量：15
2Radaideh A R, Nusier M K, Amari F L, et al. Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan[ J]. Saudi Med J, 2004,25 : 1046-1050.
3刘新民.内分泌代谢功能检查.实用内分泌学,1997,:58-63.
4Dessein P H, Joffe B I, Stanwix A E, et al. Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis[ J]. Thyroid, 2004,14:443-446.
5Canaris G J, Manowwitz N R, Mayor G, et al. The colorado thyroid disease prevalence study [ J ]. Arch Intern Med, 2000,160:526-534.
6Wilson G R, Curry R W. Subclinical thyroid disease [ J ]. Am Faro Physician, 2005,72 : 1517- 1524.
7Tuzcu A, Bahceci M, Gokalp D, et al. Subclinical hypothyroidism may be associated with elevated high-sensitive creactive protein( low grade inflammation) and fasting hyperinsulinemia [ J ]. Endocri J, 2005,52 : 89-94.
8Hak A E, Pols H A, Visser T J, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study[J]. Ann Intern Med, 2000,132:270-278.
9Diez J J, Iglesias P, Burman K D, et al. Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism [ J ]. J Clin Endocri nol Metab, 2005,90:4124- 4127.
10Vanderpump M P J, Ahlquist J A O, Franklyn J A, et al. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism[ J ]. BMJ, 1996,313:539-544.